Wilmington Funds Management’s Bristol-Myers Squibb BMY Stock Holding History

Wilmington Funds Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$1.56M	Sell	32,200 -9,645	-23%	-$475K	0.16%	153
2014 Q1	$2.17M	Sell	41,845 -8,714	-17%	-$464K	0.24%	118
2013 Q4	$2.69M	Sell	50,559 -6,105	-11%	-$311K	0.27%	111
2013 Q3	$2.62M	Sell	56,664 -2,800	-5%	-$123K	0.25%	130
2013 Q2	$2.66M	Buy	+59,464	New	+$2.58M	0.25%	132

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wilmington Funds Management's BMY Position: Q2 2014 in Review

Wilmington Funds Management reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q2 2014, selling an estimated $475K and leaving 32,200 shares worth $1.56M. The position accounts for 0.16% of the portfolio, ranked #153.

Wilmington Funds Management first reported a position in BMY in Q2 2013 and has held it in 5 quarters since. The position peaked at $2.69M in Q4 2013. 1,303 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

Wilmington Funds Management held 32,200 shares of Bristol-Myers Squibb worth $1.56M as of Q2 2014.
Wilmington Funds Management sold 9,645 Bristol-Myers Squibb shares in Q2 2014, an estimated $475K.
Bristol-Myers Squibb made up 0.16% of Wilmington Funds Management's portfolio in Q2 2014, its #153 holding.
Wilmington Funds Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 5 quarters since.
Wilmington Funds Management's Bristol-Myers Squibb position peaked at $2.69M in Q4 2013.
1,303 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.